Capricor Therapeutics | CAPR - Ebitda


Capricor Therapeutics reported $-27.23M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Bioline Rx USD -4.05M 1.8M Jun/2026
Capricor Therapeutics USD -27.23M 2.66M Jun/2025
Cipla INR 13.88B 154.2M Sep/2026
Cytokinetics USD -160.3M 9.02M Jun/2026
Geron USD -9.2M 13.03M Jun/2026
Grifols EUR 482.04M 7.04M Sep/2025
Immunic USD -22.78M 753K Jun/2024
J&J USD 8.99B 721M Jun/2026
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Prothena USD -18.49M 44.46M Jun/2026
PTC Therapeutics USD 161.9M 99.92M Jun/2026
Sarepta Therapeutics USD 30.17M 345.31M Jun/2026